Skip to main content
. Author manuscript; available in PMC: 2019 Mar 5.
Published in final edited form as: Int J Urol. 2017 Sep 15;24(10):765–770. doi: 10.1111/iju.13424

Table 2:

Multivariate analysis of prognostic variables for Overall Survival (OS) and Disease Specific Survival (DSS) in patients with kidney cancer who received care with Northern California Kaiser Permanente General from 1998–2008

  Overall Survival Disease-specific Survival

Variable Hazard Ratio 95% CI p value Hazard Ratio 95% CI p value
Age 1.04 1.03–1.05 <0.0001 1.01 1.00–1.02 0.165
Gender 0.027   1.265
   Male 1.00 (ref) 1.00 (ref)  
   Female 0.83 0.71–0.98 0.99 0.79–1.27  
Race 0.113   0.031
   White 1.00 (ref) 1.00 (ref)  
   Hispanic 1.18 0.96–1.45 1.38 1.03–1.84  
Any Renal Disease 0.67 0.44–1.02 0.063 1.38 0.50–3.77 0.533
Diabetes 0.68 0.56–0.82 <0.0001 1.03 0.76–1.40 0.853
Tumor size (cm) 1.04 1.027–1.047 <0.0001 1.05 1.04–1.06 <0.0001
Tumor Grade <0.0001 <0.0001
   Grade 1 0.45 0.33–0.62 <0.0001 0.25 0.16–0.40 <0.0001
   Grade 2 0.4 0.31–0.51 <0.0001 0.26 0.19–0.36 <0.0001
   Grade 3 0.53 0.41–0.68 <0.0001 0.55 0.41–0.73 <0.0001
   Grade 4 1.00 (ref) 1.00 (ref)  
Histological Subtype   0.364
   Clear Cell 1.00 (ref) 1.00 (ref)  
   Papillary 0.92 0.62–1.38 0.695 0.9 0.42–1.92 0.78
   Others 0.89 0.70–1.12 0.326 0.81 0.58–1.12 0.199
AJCC Stage <0.0001   <0.0001
   Stage 1 & 2 1.00 (ref) 1.00 (ref)  
   Stage 3 & 4 2.69 2.30–3.14 7.65 5.88–9.96  
Treatment Status <0.0001   <0.0001
   Surgery 1.00 (ref) 1.00 (ref)  
   No Surgery 3.79 2.95–4.88   5.74 4.23–7.81 <0.0001